APA (7th ed.) Citation

Lu, N. T., Raizer, J., Gabor, E. P., Liu, N. M., Vu, J. Q., Slamon, D. J., & Barstis, J. L. Intrathecal trastuzumab: Immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Lu, Nu T., Jeffrey Raizer, Erwin P. Gabor, Natalie M. Liu, James Q. Vu, Dennis J. Slamon, and John L. Barstis. Intrathecal Trastuzumab: Immunotherapy Improves the Prognosis of Leptomeningeal Metastases in HER-2+ Breast Cancer Patient. BMJ Publishing Group.

MLA (9th ed.) Citation

Lu, Nu T., et al. Intrathecal Trastuzumab: Immunotherapy Improves the Prognosis of Leptomeningeal Metastases in HER-2+ Breast Cancer Patient. BMJ Publishing Group.